In the HT patients, the ratio of the CD4+ IL17A+(7.49% vs. 2.72%, p<0.01) and CD4+ IFN-r+ T cells (14.23% vs. 8.85%, p<0.01) was significantly higher than that in the HC group (Figures 1A, C). The gene discussed is IL17A; the disease is hematocrit.